Financial Instruments - Schedule of Available-for-Sale Marketable Securities (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	$ 226,239	$ 218,392
Unrealized Gain	4	78
Unrealized Losses	(2,233)	(2,544)
Fair Value	224,010	215,926
Corporate Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	186,410	184,321
Unrealized Gain	4	75
Unrealized Losses	(2,034)	(2,344)
Fair Value	184,380	182,052
U.S. treasury and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	39,829	34,071
Unrealized Gain	0	3
Unrealized Losses	(199)	(200)
Fair Value	$ 39,630	$ 33,874